GSK plc Reports Share Transaction
Ticker: GLAXF · Form: 6-K · Filed: Jun 26, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-transaction, company-update
TL;DR
GSK bought back its own shares, filing details released June 26, 2025.
AI Summary
GSK plc announced on June 26, 2025, that it has completed a transaction involving its own shares. The filing, a Form 6-K, details this activity as part of its reporting for the month of June. The company, formerly known as GlaxoSmithKline plc, is based in London.
Why It Matters
This filing indicates GSK is actively managing its share capital, which can impact stock price and investor perception.
Risk Assessment
Risk Level: low — This is a routine disclosure of share transactions by the company.
Key Players & Entities
- GSK plc (company) — Registrant
- GlaxoSmithKline plc (company) — Former name of registrant
- June 26, 2025 (date) — Filing date
FAQ
What type of transaction did GSK plc announce?
GSK plc announced a transaction in its own shares.
What is the filing type and date?
The filing is a Form 6-K, filed as of June 26, 2025.
What was GSK plc formerly known as?
GSK plc was formerly known as GlaxoSmithKline plc.
Where is GSK plc's principal executive office located?
GSK plc's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Does GSK plc file annual reports under Form 20-F or 40-F?
GSK plc indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 26, 2025 regarding GSK plc (GLAXF).